Down Regulation of Wnt Signaling Mitigates Hypoxia-Induced Chemoresistance in Human Osteosarcoma CellsDonald J. Scholten, Matthew R. Steensma|PLoS ONE|2014Cited by 41
Targeting the Giant Cell Tumor Stromal Cell: Functional Characterization and a Novel Therapeutic StrategyMatthew R. Steensma, P. Edward Purdue|PLoS ONE|2013Cited by 34
Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profilingJessica Foley, Matthew R. Steensma|Journal of Translational Medicine|2015Cited by 30
NF1 deficiency drives metabolic reprogramming in ER+ breast cancerRachel J. House, Matthew R. Steensma|Molecular Metabolism|2024Cited by 13